Cationic Porphyrins as Antimicrobial and Antiviral Agents in Photodynamic Therapy

Inga O Savelyeva1, Kseniya A Zhdanova1, Margarita A Gradova2

  • 1Institute of Fine Chemical Technology, MIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.

PubMed

Insights

Antimicrobial photodynamic therapy (APDT) effectively eliminates diverse microorganisms, offering a novel approach against drug-resistant bacteria and emerging viruses. This method shows promise for combating infectious diseases and pandemics.

Area of Science:

  • Photochemistry
  • Microbiology
  • Infectious Diseases

Background:

  • Infectious diseases caused by bacteria and viruses are a major global health concern, leading to high mortality and pandemics.
  • The rise of multidrug-resistant bacteria renders existing antibiotics ineffective, necessitating novel therapeutic strategies.
  • Emerging viral pathogens pose a continuous threat, with new dangerous species identified regularly.

Purpose of the Study:

  • To review the mechanisms of antiviral and antibacterial action of antimicrobial photodynamic therapy (APDT).
  • To identify molecular targets and structure-activity relationships of cationic porphyrins used in APDT.
  • To highlight APDT as a promising alternative to conventional antimicrobial treatments.

Main Methods:

  • Literature review of studies on antimicrobial photodynamic therapy.
  • Analysis of mechanisms underlying photodynamic inactivation of viruses and bacteria.
  • Correlation analysis between cationic porphyrin structure and photodynamic activity.

Main Results:

  • APDT demonstrates broad-spectrum efficacy against various microorganisms, including bacteria and viruses.
  • Key molecular targets and pathways involved in APDT's antimicrobial action have been identified.
  • A correlation exists between the structural characteristics of cationic porphyrins and their photodynamic efficacy.

Conclusions:

  • Antimicrobial photodynamic therapy presents a potent strategy for combating both bacterial and viral infections.
  • The development of novel antimicrobial agents is crucial due to increasing drug resistance and emerging pathogens.
  • Further research into cationic porphyrins can optimize APDT for enhanced therapeutic outcomes.